Malaysia - Inggeris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn bhd - magnesium hydroxide__; aluminium hydroxide -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

actavis australia pty ltd - paracetamol -

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

remedyrepack inc. - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin 50 mg

India - Inggeris - Central Drugs Standard Control Organization

ayurlab - indometacin - syrup - nonsteroidal anti-inflammatory drug (nsaid)

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - indometacin 25mg - capsule - 25 mg - active: indometacin 25mg excipient: gelatin lactose monohydrate magnesium stearate - nonsteroidal anti-inflammatory drug (nsaid)

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - indometacin 50mg - capsule - 50 mg - active: indometacin 50mg excipient: gelatin lactose monohydrate magnesium stearate - nonsteroidal anti-inflammatory drug (nsaid)

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

viatris limited - indometacin 75mg;   - modified release capsule - 75 mg - active: indometacin 75mg   excipient: gelatin lactose monohydrate magnesium stearate maize starch methacrylic acid copolymer povidone purified talc sucrose - nonsteroidal anti-inflammatory drug (nsaid)

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin 25 mg - carefully consider the potential benefits and risks of indomethacin capsules and other treatment options before deciding to use indomethacin. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). indomethacin has been found effective in active stages of the following: - moderate to severe rheumatoid arthritis including acute flares of chronic disease. - moderate to severe ankylosing spondylitis. - moderate to severe osteoarthritis. - acute painful shoulder (bursitis and/or tendinitis). - acute gouty arthritis. indomethacin is contraindicated in patients with known hypersensitivity to indomethacin or the excipients (see description ). indomethacin should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings: anaphylactic/anaphylactoid reactions , and

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin 25 mg - carefully consider the potential benefits and risks of indomethacin capsules and other treatment options before deciding to use indomethacin. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). indomethacin has been found effective in active stages of the following: - 1.moderate to severe rheumatoid arthritis including acute flares of chronic disease. - 2.moderate to severe ankylosing spondylitis. - 3.moderate to severe osteoarthritis. - 4.acute painful shoulder (bursitis and/or tendinitis). - 5.acute gouty arthritis. indomethacin is contraindicated in patients with known hypersensitivity to indomethacin or the excipients (see description). indomethacin should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings: anaphylactic/anaphylactoid reactio

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

contract pharmacy services-pa - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin 25 mg - carefully consider the potential benefits and risks of indomethacin capsules and other treatment options before deciding to use indomethacin. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). indomethacin has been found effective in active stages of the following: - moderate to severe rheumatoid arthritis including acute flares of chronic disease. - moderate to severe ankylosing spondylitis. - moderate to severe osteoarthritis. - acute painful shoulder (bursitis and/or tendinitis). - acute gouty arthritis. indomethacin is contraindicated in patients with known hypersensitivity to indomethacin or the excipients (see description). indomethacin should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings: anaphylactic/anaphylactoid reactions, and pr